Plain-English translation of NCT03439865 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This is a small research study testing whether a medication called can help treat chronic sinus infections that haven't responded well to standard treatments. works by helping your body's natural defenses clear thick mucus from your sinuses. Half of the participants will receive standard sinus care plus this medication, while the other half will receive standard care alone.
Chronic sinus infections are a major problem affecting millions of people and causing real suffering. Current treatments โ antibiotics and steroids โ don't work well for everyone, especially when bacteria become resistant to antibiotics. Researchers believe this medication might help by fixing how your sinuses produce and clear mucus, addressing the root cause rather than just treating symptoms.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to either receive the standard sinus treatment (nasal steroid spray and antibiotics chosen based on your culture results) plus the medication, or just the standard treatment alone. You will take a 150 mg tablet of the medication (or placebo) as part of the study. The study involves imaging scans, nasal cultures, and specialized breathing tests to measure how well your sinuses are clearing mucus. Visits and follow-up testing will be scheduled to monitor how you respond to treatment.
AI-generated summary from trial data ยท Oct 12, 2026 ยท Not medical advice
United States